The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

REFERENCES

• Molina, J.R.; Yang, P.; Cassivi, S.D.; Schild, S.E.; Adjei, A.A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008, 83, 584–594.
   PubMed Web of Science ®Google Scholar
• Ray, J.M.; Stetler Stevenson, W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994, 7(11), 2062–2072.
   PubMed Web of Science ®Google Scholar
• Fortunato, S.J.; Menon, R. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes. J Assist Reprod Genet 2002, 19(10), 483–486.
   PubMed Web of Science ®Google Scholar
• Stamenkovic, I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 2003, 200(4), 448–464.
   PubMed Web of Science ®Google Scholar
• Hojilla, C.V.; Mohammed, F.F.; Khokha, R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 2003, 89(10), 1817–1821.
   PubMed Web of Science ®Google Scholar
• Imai, K.; Hiramatsu, A.; Fukushima, D.; Pierschbacher, M.D.; Okada, Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release. Biochem J 1997, 322(Pt 3), 809–814.
   PubMedGoogle Scholar
• McCawley, L.J.; Matrisian, L.M. Matrix metalloproteinases: they’re not just for matrix anymore! Curr Opin Cell Biol 2001, 13, 534–540.
   PubMed Web of Science ®Google Scholar
• Egeblad, M.; Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2, 161–174
   PubMed Web of Science ®Google Scholar
• Thomas, P.; Khokha, R.; Shepherd, F.A.; Feld, R.; Tsao, M.S. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J Pathol 2000, 190(2), 150–156.
   PubMed Web of Science ®Google Scholar
• Liu, W.W.; Zeng, Z.Y.; Wu, Q.L.; Hou, J.H.; Chen, Y.Y. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg 2005, 132(3), 395–400.
   PubMed Web of Science ®Google Scholar
• Pellikainen, J.M.; Ropponen, K.M.; Kataja, V.V.; Kellokoski, J.K.; Eskelinen, M.J.; Kosma, V.M. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 2004, 10(22), 7621–7628.
   PubMed Web of Science ®Google Scholar
• Passlick, B.; Sienel, W.; Seen Hibler, R.; Wöckel, W.; Thetter, O.; Mutschler, W.; Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000, 6(10), 3944–3948.
   PubMed Web of Science ®Google Scholar
• Ishikawa, S.; Takenaka, K.; Yanagihara, K.; Miyahara, R.; Kawano, Y.; Otake, Y.; Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostid factor in non-small cell lung cancer. Clin Cancer Res 2004, 10(19), 6579–6585.
   PubMed Web of Science ®Google Scholar
• Sier, C.F.; Zuidwijk, K.; Zijlmans, H.J.; Hanemaaijer, R.; Mulder Stapel, A.A.; Prins, F.A.; EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int J Cancer 2006, 118(12), 2991–2998.
   PubMed Web of Science ®Google Scholar
• Hoikkala, S.; Paakko, P.; Soini, Y.; Mäkitaro, R.; Kinnula, V.; Turpeenniemi Hujanen, T.; Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2–complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma. Cancer Lett 2006, 236(1), 125–132.
   PubMed Web of Science ®Google Scholar
• Shou, Y.; Hirano, T.; Gong, Y.; Kato, Y.; Yoshida, K.; Ohira, T.; Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small cell lung cancer. Br J Cancer 2001, 85(11), 1706–1712.
   PubMed Web of Science ®Google Scholar
• Leinonen, T.; Pirinen, R.; Bohm, J.; Johansson, R.; Kosma, V.M. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer. Histol Histopathol 2008, 23(6), 693–700.
   PubMed Web of Science ®Google Scholar
• Kumaki, F.; Matsui, K.; Kawai, T.; Ozeki, Y.; Yu, Z.X.; Ferrans, V.J.; Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia. Am J Pathol 2001, 159(6), 2125–2135.
   PubMed Web of Science ®Google Scholar
• Yamamura, T.; Nakanishi, K.; Hiroi, S.; Kumaki, F.; Sato, H.; Aida, S.; Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in non-small cell lung carcinomas. Lung Cancer 2002, 35(3), 249–255.
   PubMed Web of Science ®Google Scholar
• Matsuo, Y.; Hashimoto, S.C.; Koga, T.; Yonemitsu, Y.; Yoshino, I.; Sugimachi, K.; Growth pattern correlates with the distribution of basement membrane and prognosis in lung adenocarcinoma. Pathol Res Pract 2004, 200(7–8), 517–529.
   PubMed Web of Science ®Google Scholar
• Byun, J.H.; Lee, M.A.; Roh, S.Y.; Shim, B.Y.; Hong, S.H.; Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer. Japan J Clin Oncol 2006, 36(5), 263–268.
   PubMed Web of Science ®Google Scholar
• Cox, G.; Jones, J.L.; Andi, A.; Waller, D.A.; O’Byrne, K.J. A biological staging model for operable non-small cell lung cancer. Thorax 2001, 56(7), 561–566.
   PubMed Web of Science ®Google Scholar
• Steels, E.; Paesmans, M.; Berghmans, T.; Branle, F.; Lemaitre, F.; Mascaux, C.; Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 2001, 18(4), 705–719.
   PubMed Web of Science ®Google Scholar
• Parmar, M.K.; Torri, V.; Stewart, L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24), 2815–2834.
   PubMed Web of Science ®Google Scholar
• Yusuf, S.; Peto, R.; Lewis, J.; Collins, R.; Sleight, P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27(5), 335–371.
   PubMed Web of Science ®Google Scholar
• Egger, M.; Davey Smith, G.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109), 629–634.
   PubMed Web of Science ®Google Scholar
• Begg, C.B.; Berlin, J.A. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989, 81(2), 107–115.
   PubMed Web of Science ®Google Scholar
• Kodate, M.; Kasal, T.; Hashimoto, H.; Yasumoto, K.; Iwata, Y.; Manabe, H. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung. Pathol Intl 1997, 47(7), 461–469.
   PubMed Web of Science ®Google Scholar
• Begg, C.B.; Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4), 1088–1101.
   PubMed Web of Science ®Google Scholar
• DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3), 177–188.
   PubMedGoogle Scholar